OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Rheumatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Current views on lupus in children	142
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management	67
Giant cell arteritis: update on pathogenesis and clinical implications	55
Update on antineutrophil cytoplasmic autoantibody vasculitis in children	53
Editorial introduction	45
Current approach to muscle imaging in myositis	41
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence	39
Urticarial vasculitis	39
Axial spondyloarthritis guidelines – aiming for maximum impact	37
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden	34
Editorial introductions	29
Osteoporosis epidemiology using international cohorts	29
Optimizing reproductive health management in lupus and Sjogren's syndrome	28
The gut microbiota in spondyloarthritis: an update	27
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice	27
Rheumatoid arthritis – the challenge of heterogeneity	26
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials	26
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus	25
Editorial introductions	24
Updates on translational and clinical research in systemic sclerosis	23
Ribosome dysfunction in osteoarthritis	23
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation	21
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis	21
Update on gout management: what is old and what is new	19
Defining and managing flares in axial spondyloarthritis	18

Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research	18
Editorial introductions	18
The role of neutrophil extracellular traps in inflammatory rheumatic diseases	18
Editorial introduction	17
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies	17
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus	17
Animal models of vasculitis	16
Health inequities in the rheumatic diseases of childhood	16
Editorial introductions	16
Epidemiology of myositis	16
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?	14
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis	14
Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases	14
Gout and the COVID-19 pandemic	14
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0	14
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets	14
New developments related to lung complications in pediatric rheumatic disease	13
Editorial introductions	13
Editorial introductions	12
Diagnosis and management of primary heart involvement in systemic sclerosis	12
Insights into origins and specificities of autoantibodies in systemic sclerosis	12
Biomarker discovery in psoriatic disease	12
Exploring challenges in the management and treatment of inclusion body myositis	11
Polymyositis: does it really exist as a distinct clinical subset?	11
Emerging biologic therapies for systemic lupus erythematosus	11
Insights into the molecular landscape of osteoarthritis in human tissues	11
Management of postinfectious inflammatory arthritis	11
AI am the future: artificial intelligence in pediatric rheumatology	11
Investigating gout flares: beyond a definition	10
Epidemiology of osteoarthritis: literature update 2022–2023	10
Editorial introduction	10
Heart involvement in systemic sclerosis: emerging concepts	10
Vasculitis and the NLRP3 inflammasome	10
Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI	9
The association of Behçet's syndrome with HLA-B51 as understood in 2021	9
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies	9
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications	9
Gastrointestinal disease in systemic sclerosis: the neglected organ system?	9
Current management of giant cell arteritis and its complications	9
The contribution of endothelial cells to tissue fibrosis	8
Update on streptococcal-associated rheumatic disease	8
Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment	8
Pregnancies in women with antineutrophil cytoplasmatic antibody associated vasculitis	8
Animal models in systemic sclerosis: an update	8
Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children	8